On August 26, 2019 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, reported that the Company’s management will present a Company overview and update, as well as host investor meetings, at the following September conferences (Press release, Supernus, AUG 26, 2019, View Source [SID1234538997]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Wells Fargo 2019 Healthcare Conference
Date: Thursday, September 5, 2019
Time: 1:20 p.m. ET
Place: The Westin Copley Place, Boston, MA
Morgan Stanley 2019 Global Healthcare Conference
Date: Wednesday, September 11, 2019
Time: 11:05 a.m. ET
Place: Grand Hyatt New York in New York City
Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinator.
A live webcast of the presentations can be accessed by visiting ‘Events & Presentations’ in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of these webcasts will be available for 60 days on the Company’s website after the conference.